Potential of ADAM 17 Signal Peptide To Form Amyloid Aggregates in Vitro

Taniya Bhardwaj1, Rajanish Giri1

  • 1School of Biosciences and Bioengineering, Indian Institute of Technology Mandi, VPO Kamand, Mandi, Himachal Pradesh 175075, India.

PubMed

Insights

The ADAM 17 signal peptide (ADAM 17-SP) can form amyloid-like aggregates in vitro. These aggregates can accelerate amyloid beta 42 (Aβ42) peptide aggregation, suggesting a novel role for signal peptides.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Protein Aggregation

Background:

  • ADAM 17 is a metalloproteinase crucial for cellular regulation.
  • The signal peptide of ADAM 17 (ADAM 17-SP) directs proteins to the secretory pathway.
  • The intracellular function of ADAM 17-SP beyond signaling is largely unknown.

Purpose of the Study:

  • To investigate the biophysical properties of ADAM 17-SP.
  • To determine if ADAM 17-SP can form aggregates.
  • To explore the interaction of ADAM 17-SP aggregates with amyloid beta 42 (Aβ42) peptide.

Main Methods:

  • In vitro aggregation assays of ADAM 17-SP.
  • Aggregation studies in the presence of cellular biomolecules (sodium tripolyphosphate, heparin).
  • Seeding experiments with Aβ42 peptide.

Main Results:

  • ADAM 17-SP contains aggregation-prone segments.
  • ADAM 17-SP forms amyloid-like aggregates under buffered conditions.
  • ADAM 17-SP seeds accelerate Aβ42 aggregation and form heteromeric aggregates.

Conclusions:

  • ADAM 17-SP exhibits self-aggregation properties.
  • ADAM 17-SP aggregation may influence other amyloidogenic peptides like Aβ42.
  • This study highlights a potential novel intracellular role for signal peptides in protein aggregation.